April 17, 2026 10:26 am

Tag: Crohn’s symptoms

New Hope for Severe Crohn’s: Breakthrough Drug Targets Scarring

Agomab Therapeutics has launched a groundbreaking clinical trial for ontunisertib, a drug specifically targeting fibrostenosing Crohn’s disease—the severe, scarring form that has limited treatment options. This represents the first targeted therapy designed to address the root cause of intestinal scarring rather than just managing symptoms.

You Missed

Vitamin D Shows Promise for Resetting Immune Response in IBD: What This Could Mean for Your Treatment

Vitamin D Shows Promise for Resetting Immune Response in IBD: What This Could Mean for Your Treatment

April 12, 2026
Low-FODMAP Diet for Crohn's Disease: Managing Symptoms Without Treating Inflammation

Low-FODMAP Diet for Crohn’s Disease: Managing Symptoms Without Treating Inflammation

April 11, 2026
New Research Reveals Promising Results for Fecal Microbiota Transplantation in IBD Treatment

New Research Reveals Promising Results for Fecal Microbiota Transplantation in IBD Treatment

April 10, 2026
Is My Extreme Fatigue From IBD or Something Else? Understanding the Complex Causes of Exhaustion

Is My Extreme Fatigue From IBD or Something Else? Understanding the Complex Causes of Exhaustion

April 10, 2026